Serum Institute to invest $68 million in Oxford Biomedica Reuters Sep 23, 2021 As part of the deal, Serum Life Sciences, a unit of SII, will pick up a 3.9 per cent stake in Oxford Biomedica
Serum Institute of India to make £240 mn investments in UK Press Trust of India May 4, 2021 Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines
COVID-19 vaccines worth Rs 338 crores exported from India so far: Piyush Goyal Press Trust of India Feb 12, 2021 The exports include grant of the vaccine doses to friendly countries and commercial shipments.
COVID-19 vaccines supply may meet, even exceed demand in India by third quarter: AstraZeneca India… Press Trust of India Jan 29, 2021 For any vaccine to be meaningful in the current pandemic, it has to be made available broadly, equitably and timely, he said
India likely to approve AstraZeneca vaccine by next week – sources Reuters Dec 23, 2020 India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the…
Modi visits key vaccine facilities as COVID-19 case load surges Reuters Nov 28, 2020 The Prime Minister Narendra Modi toured three of the nation’s leading vaccine development and manufacturing sites on Saturday as…
Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus Press Trust of India Jul 20, 2020 Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the…
40 vaccines are under development: ICMR EP News Bureau Apr 12, 2020 None have reached the next stage yet